The notable progress and potential future of cellular therapy for solid tumors seen throughout 2024 signify a transformational year in oncology. The general sentiment within the oncology community is optimistic, particularly with the U.S. Food and Drug Administration's approval of the first
Craniotomy, a common surgical procedure performed to remove brain tumors, carries a significant risk of inducing seizures in patients, a complication that can lead to increased cerebral pressure, aspiration pneumonia, and prolonged hospital stays. Although guidelines generally discourage routine
When thinking about the remarkable advancements in multiple myeloma treatment, CAR T-cell therapy generates immense excitement due to its potential to provide deep and enduring responses for patients. Dr. Nina Shah, Global Head of Multiple Myeloma Clinical Development and Strategy at AstraZeneca,
Checkpoint inhibitor therapies have revolutionized cancer treatment by enhancing the immune system's ability to target and destroy cancer cells. By boosting the immune response, these therapies have made significant strides in prolonging the lives of patients with various types of cancer.
In a groundbreaking development, scientists have devised an innovative method for evaluating the oxygen delivery effectiveness of red blood cells (RBCs) by analyzing their shape. This advancement holds the potential to significantly enhance practices in transplant and transfusion medicine, as well
Lung fibrosis, or pulmonary fibrosis, is a debilitating disease characterized by the excessive buildup of fibrillar collagen, leading to scarring in the lung tissue. This scarring makes lung tissues stiff and reduces their elasticity, resulting in severe breathing difficulties and decreased oxygen
